Mycotopia Therapies, Inc. (TPIA)

USD 0.02

(-5.0%)

Market Cap (In USD)

113.82 Thousand

Revenue (In USD)

-

Net Income (In USD)

-1.18 Million

Avg. Volume

173.84 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.01-0.18
PE
-0.1462
EPS
-0.13
Beta Value
2.558
ISIN
US62846W1071
CUSIP
62846W107
CIK
1763329
Shares
5990900.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Mr. Benjamin Kaplan
Employee Count
-
Website
https://www.mycotopiatherapies.com
Ipo Date
2006-03-31
Details
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. The company is based in Aventura, Florida. Mycotopia Therapies, Inc. is a subsidiary of EHAVE, Inc.